LEAH FURMAN: Open Payments
NPI 1487385506 · POST FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 20 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $111 · 2025 $815
Food & beverage: $815
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 4 | $240 |
| Sequel Med Tech, LLC | 1 | $142 |
| Novo Nordisk Inc | 1 | $125 |
| Dexcom, Inc. | 3 | $57 |
| BETA BIONICS, INC. | 2 | $50 |
| Lilly USA, LLC | 2 | $41 |
| ABBVIE INC. | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $25 |
| PFIZER INC. | 1 | $24 |
Products named: Omnipod, TWIIST, Wegovy, Dexcom G6 Transmitter, iLet Bionic Pancreas, MOUNJARO, UBRELVY, ABILIFY MAINTENA.
Industry payments across ID — which companies pay providers there.
